Eine Gruppe von Antibiotika antibiotika-wiki.de , zu denen das Natürliche Antibiotikum Lincomycin und sein halbsynthetisches Analogon Clindamycin gehören. Sie haben bakteriostatische oder bakterizide Eigenschaften, abhängig von der Konzentration im Körper und der Empfindlichkeit von Mikroorganismen. Die Wirkung ist auf die Unterdrückung der Proteinsynthese in Bakterienzellen durch Bindung DER 30s-Subeinheit der ribosomalen Membran zurückzuführen. Lincosamide sind resistent gegen die Wirkung von Salzsäure Magensaft. Nach oraler Verabreichung wird schnell absorbiert. Es wird für Infektionen verwendet, die durch Gram-positive Kokken (hauptsächlich als Medikamente der zweiten Reihe) und unvorhersehbare anaerobe Flora verursacht werden. Cuando se vincula un sitio web que vende productos farmacéuticos desde otro sitio - comprar-farmacia.es, como Search Engine Marketing a través del programa AdSense de Google, la degradación resultante puede disminuir drásticamente la cantidad de ingresos publicitarios obtenidos por el sitio web. Lo mismo se aplica a cualquier inclusión pagada. Esencialmente, el servidor de anuncios sirve una página desde su propio dominio. Si la página contiene un banner (es decir, una imagen) del dominio de una marca, la marca recibirá una parte de los ingresos publicitarios.

Microsoft word - 100_d_0

G/SPS/N/TPKM/303
Committee on Sanitary and Phytosanitary Measures
NOTIFICATION
Notifying Member: THE SEPARATE CUSTOMS TERRITORY OF TAIWAN, PENGHU,
If applicable, name of local government involved:
Agency responsible: Ministry of Health and Welfare
Products covered (provide tariff item number(s) as specified in national
schedules deposited with the WTO; ICS numbers should be provided in
addition, where applicable): Livestock and poultry tissues
Regions or countries likely to be affected, to the extent relevant or practicable:
partners
Specific regions or countries:
Title of the notified document: Draft Standards for Veterinary Drug Residue Limits in
Foods Language(s): Chinese and English Number of pages: 14
http://members.wto.org/crnattachments/2014/SPS/CHT/14_0074_00_e.pdf http://members.wto.org/crnattachments/2014/SPS/CHT/14_0074_00_x.pdf Description of content: Amendment to maximum residue limit for Amoxicillin,
Ampicillin, Amprolium, Arsanilic acid, Benzylpenicillin, Procaine benzylpenicillin,
Bicozamycin, Cefuroxime, Chlortetracycline, Oxytetracycline, Tetracycline, Clopidol, Cloxacillin, Diaveridine, Doxycycline, Ethopabate, Florfenicol, Flunixin, Hydrocortisone, Josamycin, Kanamycin, Lasalocid, Levamisole, Lincomycin, Maduramicin, Mebendazole, Nosiheptide, Oleandomycin, Orbifloxacin, Oxolinic acid, Piperazine, Prednisolone, Pyrantel, Pyrimethamine, Semduramicin, Spectinomycin, Spiramycin, Sulfamonomethoxine, Tiamulin and Trimethoprim. Objective and rationale: [X] food safety, [ ] animal health, [ ] plant protection,
[ ] protect humans from animal/plant pest or disease, [ ] protect territory from
other damage from pests.
Is there a relevant international standard? If so, identify the standard:
Codex Alimentarius Commission (e.g. title or serial number of Codex
standard or related text)
World Organization for Animal Health (OIE) (e.g. Terrestrial or Aquatic
Animal Health Code, chapter number)
International Plant Protection Convention (e.g. ISPM number)
Does this proposed regulation conform to the relevant international standard?
[ ] Yes [ ] No
If no, describe, whenever possible, how and why it deviates from the
international standard:
Other relevant documents and language(s) in which these are available: Draft
Standards for Veterinary Drug Residue Limits in Foods (31 December 2013, Food
No. 1021351962) is available in English from the National Notification Authority, National Enquiry Point, and Ministry of Health and Welfare. The amendment will be published in the Official Government Gazette when adopted. The full texts may be downloaded from the following website: http://www.fda.gov.tw English Proposed date of adoption (dd/mm/yy): To be determined.
Proposed date of publication (dd/mm/yy): To be determined.
Proposed date of entry into force: [ ] Six months from date of publication,
and/or (dd/mm/yy): To be determined.
Trade facilitating measure
Final date for comments: [X] Sixty days from the date of circulation of the
notification and/or (dd/mm/yy): 11 March 2014
Agency or authority designated to handle comments: [X] National Notification
Authority, [X] National Enquiry Point. Address, fax number and e-mail address
(if available) of other body:
Food and Drug Administration Ministry of Health and Welfare No.161-2, Kunyang St., Nangang District, Taipei City 115-61, Taiwan (R.O.C.) Fax: +(886 2) 2653 1062 E-mail: 1587syj@fda.gov.tw Texts available from: [X] National Notification Authority, [X] National Enquiry
Point. Address, fax number and e-mail address (if available) of other body:
Ministry of Health and Welfare No.161-2, Kunyang St., Nangang District, Taipei City 115-61, Taiwan (R.O.C.)

Source: http://www.sfs.fi/files/4514/GSPSNTPKM303.pdf